Results
3841
Companies which are more than 50% undervalued based on analyst price target.
3,841 companies
Yakkyo
Market Cap: €5.5m
Operates an e-commerce platform in Italy and internationally.
YKY
€1.00
7D
0%
1Y
0%
International Care
Market Cap: €5.5m
Provides digital health care services in Italy and internationally.
ICC
€1.15
7D
0.9%
1Y
-2.5%
Lipella Pharmaceuticals
Market Cap: US$6.1m
A clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications.
LIPO
US$2.39
7D
-1.2%
1Y
-60.9%
Ebusco Holding
Market Cap: €5.5m
Engages in the development, manufacture, and distribution of zero emission buses and charging systems.
EBUS
€0.42
7D
33.4%
1Y
-97.4%
Society Pass
Market Cap: US$6.0m
Acquires and operates fintech and e-commerce platforms and mobile applications for consumers and merchants in Indonesia, Vietnam, the Philippines, Singapore, the United States, Thailand, and Malaysia.
SOPA
US$1.19
7D
3.5%
1Y
-38.3%
SGT German Private Equity GmbH KGaA
Market Cap: €5.4m
Acquires, fosters, and sells stakes in established businesses.
GAI
€0.56
7D
5.7%
1Y
-5.9%
FGI Industries
Market Cap: US$5.9m
FGI Industries ltd. supplies bath and kitchen products retail, wholesale, commercial and specialty channel customers in the United States, Canada, Europe, and internationally.
FGI
US$0.55
7D
-6.1%
1Y
-46.7%
Questor Technology
Market Cap: CA$8.3m
An environmental emissions reduction technology company, designs, manufactures, and services clean combustion systems in Canada and the United States.
QST
CA$0.30
7D
3.4%
1Y
-45.5%
T Stamp
Market Cap: US$5.9m
Develops and markets identity authentication software solutions for government and enterprise partners, and peer-to-peer markets worldwide.
IDAI
US$2.31
7D
12.1%
1Y
-77.4%
Soligenix
Market Cap: US$5.9m
A late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States.
SNGX
US$1.90
7D
-3.6%
1Y
-67.3%
GENinCode
Market Cap: UK£4.4m
Develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient’s health based on their genes in the United Kingdom and internationally.
GENI
UK£0.015
7D
-3.1%
1Y
-81.8%
OncoZenge
Market Cap: SEK 57.3m
A pharmaceutical company, engages in the development of treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer in Sweden.
ONCOZ
SEK 4.89
7D
18.0%
1Y
29.2%
sdm
Market Cap: €5.2m
Sdm SE provides security services in the Munich metropolitan region.
75S
€1.38
7D
-4.2%
1Y
-46.5%
Grid Metals
Market Cap: CA$8.2m
Engages in the exploration and development of base and precious metal mineral properties in Canada.
GRDM
CA$0.04
7D
0%
1Y
-50.0%
Circio Holding
Market Cap: NOK 60.4m
A biotechnology company, develops novel circular RNA and immunotherapy medicines.
CRNA
NOK 0.67
7D
-5.0%
1Y
-69.6%
PAULIC Meunerie
Market Cap: €5.1m
Produces and sells wheat and buckwheat flour for professionals in the bakery, creperie, and food industries in France and internationally.
ALPAU
€1.11
7D
13.3%
1Y
-38.3%
Arcadia Biosciences
Market Cap: US$5.6m
Produces and markets plant-based food and beverage products in the United States.
RKDA
US$4.16
7D
-3.3%
1Y
43.4%
Kalray
Market Cap: €5.0m
Provides processors and acceleration cards in France.
ALKAL
€0.45
7D
-20.1%
1Y
-97.6%
MetaVia
Market Cap: US$5.6m
A clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases.
MTVA
US$0.67
7D
-2.1%
1Y
-84.3%
Méthanor
Market Cap: €5.0m
A renewable energy company, finances and operates renewable energy projects in France.
ALMET
€2.07
7D
-6.1%
1Y
-18.4%
Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft
Market Cap: €5.0m
Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG is private equity and venture capital firm specializing in mid venture, late venture, turnaround, mezzanine, bridge financing, buy and build and expansion stage investments in medium sized companies.
EFF
€0.30
7D
1.4%
1Y
-56.2%
GT Biopharma
Market Cap: US$5.5m
A clinical stage biopharmaceutical company, engages in the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) and Tetra-specific Killer Engager (Dual Targeting TriKE) fusion protein immune cell engager technology platforms.
GTBP
US$2.19
7D
-7.8%
1Y
-28.2%
Golden Arrow Resources
Market Cap: CA$7.6m
A natural resource company, engages in the acquisition, exploration, and development of mineral resource properties in South America.
GRG
CA$0.045
7D
-10.0%
1Y
-25.0%
Theriva Biologics
Market Cap: US$5.4m
A clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the United States.
TOVX
US$0.57
7D
-30.0%
1Y
-93.9%
CaliberCos
Market Cap: US$5.3m
A real estate investment, and an asset management firm specializes in middle-market assets.
CWD
US$4.10
7D
-13.9%
1Y
-76.7%
Workhorse Group
Market Cap: US$5.3m
A technology company, engages in design, manufacture, and sale of zero-emission commercial vehicles in the United States.
WKHS
US$0.99
7D
-7.9%
1Y
-98.2%
Criterium Energy
Market Cap: CA$7.4m
Engages in the exploration and development of oil and gas in Indonesia and Canada.
CEQ
CA$0.055
7D
10.0%
1Y
-15.4%
Canadian Critical Minerals
Market Cap: CA$7.3m
An exploration stage company, engages in the acquisition, exploration, and development of precious metals in Canada.
CCMI
CA$0.025
7D
0%
1Y
-58.3%
urban-gro
Market Cap: US$5.2m
Engages in the designing, engineering, building, and integrating complex environmental equipment systems for indoor controlled environment agriculture (CEA) cultivation and retail facilities in the United States, Canada, and Europe.
UGRO
US$0.39
7D
-9.1%
1Y
-74.0%
Predict
Market Cap: €4.6m
Designs, develops, and sells medical diagnostic imaging systems in Italy.
PRE
€0.64
7D
1.6%
1Y
n/a
E-Pango
Market Cap: €4.5m
Operates as an electricity and gas supplier.
ALAGO
€0.16
7D
-3.7%
1Y
-49.5%
ExpreS2ion Biotech Holding
Market Cap: SEK 49.2m
Through its subsidiary, ExpreS2ion Biotechnologies ApS, researches and develops preventive and therapeutic vaccine products in the Nordics and internationally.
EXPRS2
SEK 18.52
7D
-1.1%
1Y
-67.8%
Rakovina Therapeutics
Market Cap: CA$7.0m
A biopharmaceutical research company, engages in the research and development of cancer treatments based on novel series of small-molecule DNA-damage response targets.
RKV
CA$0.05
7D
11.1%
1Y
-44.4%
AcouSort
Market Cap: SEK 48.5m
A technology company, develops products and solutions for automated preparation of biological samples based on acoustofluidics technology for researchers and life science companies.
ACOU
SEK 3.25
7D
1.2%
1Y
-66.8%
Sunshine Biopharma
Market Cap: US$4.9m
Operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada.
SBFM
US$1.39
7D
9.4%
1Y
-92.2%
Rockfire Resources
Market Cap: UK£3.7m
Engages in the exploration of base metals and critical minerals in Greece and Australia.
ROCK
UK£0.0009
7D
0%
1Y
-52.6%